These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 15751)

  • 1. Clotting in dialyzers due to low pH of dialysis fluid.
    Schwarzbeck A; Wagner L; Squarr HU; Strauch M
    Clin Nephrol; 1977 Mar; 7(3):125-7. PubMed ID: 15751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Eloot S; de Vos JY; de Vos F; Hombrouckx R; Verdonck P
    Hemodial Int; 2005 Oct; 9(4):399-408. PubMed ID: 16219061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational evaluation of dialysis fluid flow in dialyzers with variously designed jackets.
    Yamamoto K; Matsuda M; Hirano A; Takizawa N; Iwashima S; Yakushiji T; Fukuda M; Miyasaka T; Sakai K
    Artif Organs; 2009 Jun; 33(6):481-6. PubMed ID: 19473145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hemodialysis on endogenous middle molecules in uremic patients.
    Asaba H; Fürst P; Oulés R; Yahiel V; Zimmerman L; Bergström J
    Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased dialyzer reuse with citrate dialysate.
    Ahmad S; Callan R; Cole J; Blagg C
    Hemodial Int; 2005 Jul; 9(3):264-7. PubMed ID: 16191076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of hemodialyzers' designs.
    Twardowski ZJ
    Hemodial Int; 2008 Apr; 12(2):173-210. PubMed ID: 18394051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of bacteremia and endotoxemia despite contaminated dialyzate.
    Bernick JJ; Port FK
    Clin Nephrol; 1980 Jul; 14(1):13-7. PubMed ID: 7408251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [State of the art and outlook for promoting Russian-made hemodialysis equipment with regeneration of dialyzing solution].
    Viktorov VA; Varin AN; Grinval'd VM; Maksimov EP; Fomicheva NN; Zavalishin IuK; Leshchinskiĭ GM; Razhev II; Noskov SG; Shadiev BSh; Rodin VV; Strelkov SI; Shukov OV; Turiaev AD; Shishkin SV
    Med Tekh; 2003; (1):16-21. PubMed ID: 12608066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
    Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P
    Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialyzers.
    Gunnarsson B; Asaba H; Dawidson S; Wilhelmsson S; Bergström J
    Clin Nephrol; 1981 Mar; 15(3):135-42. PubMed ID: 7273488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical characterization of dialysis fluid flow of newly developed dialyzers using mass transfer correlation equations.
    Kunikata S; Fukuda M; Yamamoto K; Yagi Y; Matsuda M; Sakai K
    ASAIO J; 2009; 55(3):231-5. PubMed ID: 19357496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
    Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodialysis without heparin.
    Woods HF; Weston MJ; Bunting S
    Proc Eur Dial Transplant Assoc; 1978; 15():122-9. PubMed ID: 368769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis dementia: the role of dialysate pH in altering the dialyzability of aluminum.
    Gacek EM; Babb AL; Uvelli DA; Fry DL; Scribner BH
    Trans Am Soc Artif Intern Organs; 1979; 25():409-15. PubMed ID: 43004
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement in disequilibrium symptoms during dialysis with low glucose dialyzate.
    Raju SF; White AR; Barnes TT; Smith PP; Kirchner KA
    Clin Nephrol; 1982 Sep; 18(3):126-9. PubMed ID: 7140023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of dialysis fluid composition on the blood pressure response during dialysis.
    Wehle B; Asaba H; Castenfors J; Fürst P; Grahn A; Gunnarsson B; Shaldon S; Bergström J
    Clin Nephrol; 1978 Aug; 10(2):62-6. PubMed ID: 29737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.